Ken Griffin Eli Lilly & CO Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $400 Million - $497 Million	517,500 Added 39.62%	1,823,600 $1.62 Billion
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $306 Million - $384 Million	-422,600 Reduced 24.45%	1,306,100 $1.18 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $246 Million - $329 Million	415,700 Added 31.66%	1,728,700 $1.34 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $87.5 Million - $103 Million	166,700 Added 14.54%	1,313,000 $765 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $51.9 Million - $71.6 Million	-119,500 Reduced 9.44%	1,146,300 $616 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $93.3 Million - $125 Million	265,900 Added 26.59%	1,265,800 $594 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $23.3 Million - $27.4 Million	-75,000 Reduced 6.98%	999,900 $343 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $127 Million - $148 Million	-395,100 Reduced 26.88%	1,074,900 $393 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $283 Million - $323 Million	955,700 Added 185.83%	1,470,000 $475 Million

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.